Adverse Events of Adjuvant Mitotane Treatment for Adrenocortical Carcinoma

被引：0
|
作者：
Vodanovic, Ivana Dora [1 ]
Nekic, Anja Barac [1 ]
Sambula, Lana [2 ]
Tomsic, Karin Zibar [1 ]
Dusek, Tina [1 ,3 ]
Kastelan, Darko [1 ,3 ]
机构：
[1] Univ Hosp Ctr Zagreb, Dept Endocrinol, Kispaticeva 12, Zagreb 10000, Croatia
[2] Gen Hosp Tomislav Bardek, Dept Nephrol Endocrinol & Diabetol, Koprivnica, Croatia
[3] Univ Zagreb, Sch Med, Zagreb, Croatia
来源：
ENDOCRINE RESEARCH | 2025年 / 50卷 / 01期
关键词：
Adjuvant treatment; adrenal insufficiency; adrenocortical carcinoma; adverse event; hydrocortisone replacement; mitotane; EUROPEAN NETWORK; PLASMA;
D O I：
10.1080/07435800.2024.2402311
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BackgroundMitotane is the cornerstone of adjuvant adrenocortical cancer (ACC) treatment. However, its use is burdened with frequent adverse events.MethodsA retrospective analysis of adverse events was performed in 26 ACC patients adjuvantly treated with mitotane.ResultsMitotane toxicity was present in all patients (100%). Two (7.7%) patients developed 1-3 adverse events, 15 (57.7%) experienced 4-6 adverse events and 9 (34.6%) patients had more than 6 adverse events. Two (7.7%) patients discontinued mitotane due to adverse events.ConclusionCareful monitoring and timely management are essential for ensuring mitotane treatment adherence and maximizing its benefits.
引用
收藏
页码：50 / 56
页数：7
相关论文
共 50 条
  • [1] Adjuvant mitotane treatment for adrenocortical carcinoma
    Terzolo, Massimo
    Angeli, Alberto
    Fassnacht, Martin
    Daffara, Fulvia
    Tauchmanova, Libuse
    Conton, Pier Antonio
    Rossetto, Ruth
    Buci, Lisa
    Sperone, Paola
    Grossrubatscher, Erika
    Reimondo, Giuseppe
    Bollito, Enrico
    Papotti, Mauro
    Saeger, Wolfgang
    Hahner, Stefanie
    Koschker, Ann-Cathrin
    Arvat, Emanuela
    Ambrosi, Bruno
    Loli, Paola
    Lombardi, Gaetano
    Mannelli, Massimo
    Bruzzi, Paolo
    Mantero, Franco
    Allolio, Bruno
    Dogliotti, Luigi
    Berruti, Alfredo
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (23): : 2372 - 2380
  • [2] Adjuvant mitotane in adrenocortical carcinoma
    Bertherat, Jerome
    Coste, Joel
    Bertagna, Xavier
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (12): : 1256 - 1257
  • [3] Adjuvant mitotane in adrenocortical carcinoma - Reply
    Terzolo, Massimo
    Fassnacht, Martin
    Berruti, Alfredo
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (12): : 1259 - 1259
  • [4] Neurological adverse events of mitotane in adrenocortical carcinoma: results of a pilot study
    Mormando, Marilda
    Galie, Edvina
    Bianchini, Marta
    Lauretta, Rosa
    Puliani, Giulia
    Tanzilli, Antonio
    Anceschi, Umberto
    Simone, Giuseppe
    Petreri, Gianluca
    Graziano, Giuliana
    Pace, Andrea
    Appetecchia, Marialuisa
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] Adjuvant mitotane treatment after adrenalectomy is not beneficial for adrenocortical carcinoma
    Dralle, H.
    CHIRURG, 2016, 87 (11): : 980 - 980
  • [6] Mitotane treatment for adrenocortical carcinoma: an overview
    De Francia, S.
    Ardito, A.
    Daffara, F.
    Zaggia, B.
    Germano, A.
    Berruti, A.
    Di Carlo, F.
    MINERVA ENDOCRINOLOGICA, 2012, 37 (01) : 9 - 23
  • [7] Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment
    Puglisi, Soraya
    Calabrese, Anna
    Basile, Vittoria
    Ceccato, Filippo
    Scaroni, Carla
    Simeoli, Chiara
    Torlontano, Massimo
    Cannavo, Salvatore
    Arnaldi, Giorgio
    Stigliano, Antonio
    Malandrino, Pasqualino
    Saba, Laura
    Altieri, Barbara
    Della Casa, Silvia
    Perotti, Paola
    Berchialla, Paola
    De Filpo, Giuseppina
    Canu, Letizia
    Loli, Paola
    Reimondo, Giuseppe
    Terzolo, Massimo
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (11)
  • [8] Practical treatment using mitotane for adrenocortical carcinoma
    Terzolo, Massimo
    Zaggia, Barbara
    Allasino, Barbara
    De Francia, Silvia
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2014, 21 (03) : 159 - 165
  • [9] New perspectives for mitotane treatment of adrenocortical carcinoma
    Puglisi, S.
    Calabrese, A.
    Basile, V
    Pia, A.
    Reimondo, G.
    Perotti, P.
    Terzolo, M.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 34 (03)
  • [10] MITOTANE IN ADRENOCORTICAL CARCINOMA
    VASSILOPOULOUSELLIN, R
    GUINEE, VF
    BRITISH JOURNAL OF CANCER, 1994, 70 (04) : 779 - 779
12345